SAT466 Inactive Thyroid Eye Disease Patient Journey

Disclosure: K. Cockerham: Consulting Fee; Self; Horizon Therapeutics plc, Viridian. T.J. Smith: Consulting Fee; Self; Horizon Therapeutics plc, Viridian, Lundbeck. Other; Self; US patents covering the use of IGF-1 receptor inhibitors in TED which are held by UCLA and the Lundquist Institute. E. Conr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cockerham, Kimberly, Smith, Terry J, Conrad, Elizabeth, Holt, Robert J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553666/
http://dx.doi.org/10.1210/jendso/bvad114.1940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553666/
http://dx.doi.org/10.1210/jendso/bvad114.1940

Ejemplares similares